Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

June 03, 2015 5:04 PM ET


Company Overview of Euclises Pharmaceuticals, Inc.

Company Overview

Euclises Pharmaceuticals, Inc. researches, develops, and commercializes medicines in the field of inflammation and oncology. Euclises Pharmaceuticals, Inc. was formerly known as Talley NewCo, Inc. The company was incorporated in 2011 and is based in St. Louis, Missouri.

4320 Forest Park Avenue

Suite 303

St. Louis, MO 63108

United States

Founded in 2011



Key Executives for Euclises Pharmaceuticals, Inc.

Chief Executive Officer, President and Director
Age: 61
Compensation as of Fiscal Year 2014.

Euclises Pharmaceuticals, Inc. Key Developments

Euclises Announces Executive Changes

Euclises Pharmaceuticals, Inc. announced that Bobby W. Sandage, Jr., Ph.D., has joined the company as its President and CEO. He replaces Rajesh Devraj, Ph.D., who remains on the Euclises Board of Directors. Dr. Sandage brings three decades of experience and a successful track record of driving new medicines through development and into clinical practice. He most recently served as President and CEO of Coronado Biosciences and was previously vice president of Covidien Pharmaceuticalsâ oncology R&D program. For 19 years, Dr. Sandage was the CSO and EVP of R&D at Indevus Pharmaceuticals, which was acquired by Endo Pharmaceuticals in 2009. Prior to Indevus, he held senior drug development positions at DuPont Merck Pharmaceutical Company, DuPont/American Critical Care, Merrell Dow, and Dow Pharmaceuticals.

Similar Private Companies By Industry

Company Name Region
Bayer Corporation United States
Dowpharma Contract Manufacturing Services United States
Helsinn Therapeutics (U.S.), Inc. United States
Sigma-Tau Pharmaceuticals, Inc. United States
Pharmanex, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Euclises Pharmaceuticals, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at